Background-Cholera toxin causes small intestinal hypersecretion by inducing
a coordinated response from enterocytes, enterochromaffin cells, enteric n
eurones, and the vascular supply. Nitric oxide has been implicated in the f
unction of these separate components.
Aims-To explore the role of nitric oxide in the totality of cholera toxin i
nduced secretion in vivo.
Methods-One group of adult male Wistar rats was treated with the nitric oxi
de synthase inhibitors N-G-nitro-L-arginine methyl ester (L-NAME; subcutane
ously or intraluminally), N-G-methyl-L-arginine (L-NMA), or 7-nitroindazole
. A second group of rats was treated with L-arginine (intraperitoneally or
intraluminally) or D-arginine. The small intestine was isolated between two
cannulae and instilled with 75 mu g cholera toxin or saline for two hours.
Small intestinal perfusion of a plasma electrolyte solution containing [C-
14]-PEG was undertaken to determine net water and electrolyte movement. Aft
er the experiment macroscopic and microscopic intestinal appearances were n
oted and jejunal 5-hydroxytryptamine concentrations were determined.
Results-Both L-arginine and L-NAME induced secretion in the basal state, bu
t only when administered intraluminally. Systemically applied L-NAME caused
a dose dependent reduction in cholera toxin induced secretion. This was pa
ralleled by L-NMA but not by 7-nitroindazole or by intraluminally applied L
-NAME. Systemically applied L-NAME caused notable cyanosis of the intestine
, consistent with mesenteric ischaemia, but no microscopic abnormalities. S
ystemically applied L-arginine but not D-arginine also reduced cholera toxi
n induced secretion and inhibited 5-hydroxytryptamine release.
Conclusion-Nitric oxide has a duality of roles in cholera toxin induced sec
retion, acting both as an absorbagogue and a acting both as an absorbagogue
ana a Secretagogue. Its mechanisms of action include the maintenance of mu
cosal perfusion and enterochromaffin cell stabilisation.